Rights and permissions
About this article
Cite this article
Dihydroergotamine mesilate for migraine: phase III trial initiated. Inpharma Wkly. 1647, 5 (2008). https://doi.org/10.2165/00128413-200816470-00016
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200816470-00016